Search Results - "Lumbreras Bermejo, C"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Which one is a better predictor of prognosis in COVID-19: analytical biomarkers or PaO2/FiO2? by Rubio-Rivas, M., Mora-Luján, J.M., Sáez, A.M., Martín-Escalante, M.D., Galvañ, V.G., de la Calle, G.M., Taboada Martínez, M.L., Míguez, A.M., Lumbreras-Bermejo, C., Antón-Santos, J.-M.

    “…The study aimed to describe patient characteristics and outcomes by PaO2/FiO2 (PAFI) and degree of inflammation. Retrospective cohort study with data on…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections by Aguado-García, José María, Martín-Herrero, José Emilio, Lumbreras-Bermejo, Carlos

    “…The choice of antibiotic therapy in respiratory tract infections is usually empirical. However, this choice is complicated by the increasing prevalence of…”
    Get full text
    Journal Article
  7. 7

    Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients by Cobo Reinoso, P, Aguado García, J M, Lumbreras Bermejo, C, Pérez Vela, J L, Caballero Cubedo, R, Sanz Sanz, F, Noriega Rodríguez, A R

    Published in Revista clínica espanõla (01-12-1997)
    “…To analyze the epidemiologic characteristics of non-neutropenic patients with candidemia in a general hospital and the advantages and disadvantages of…”
    Get more information
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11